Ident. | Authors (with country if any) | Title |
---|
000193 (2020) |
Roujian Lu [République populaire de Chine] ; Xiang Zhao [République populaire de Chine] ; Juan Li [République populaire de Chine] ; Peihua Niu [République populaire de Chine] ; Bo Yang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Wenling Wang [République populaire de Chine] ; Hao Song [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Na Zhu [République populaire de Chine] ; Yuhai Bi [République populaire de Chine] ; Xuejun Ma [République populaire de Chine] ; Faxian Zhan [République populaire de Chine] ; Liang Wang [République populaire de Chine] ; Tao Hu [République populaire de Chine] ; Hong Zhou [République populaire de Chine] ; Zhenhong Hu [République populaire de Chine] ; Weimin Zhou [République populaire de Chine] ; Li Zhao [République populaire de Chine] ; Jing Chen [République populaire de Chine] ; Yao Meng [République populaire de Chine] ; Ji Wang [République populaire de Chine] ; Yang Lin [République populaire de Chine] ; Jianying Yuan [République populaire de Chine] ; Zhihao Xie [République populaire de Chine] ; Jinmin Ma [République populaire de Chine] ; William J. Liu [République populaire de Chine] ; Dayan Wang [République populaire de Chine] ; Wenbo Xu [République populaire de Chine] ; Edward C. Holmes [Australie] ; George F. Gao [République populaire de Chine] ; Guizhen Wu [République populaire de Chine] ; Weijun Chen [République populaire de Chine] ; Weifeng Shi [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] | Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding |
000297 (2020) |
Abdullah Sheikh [Arabie saoudite] ; Abdulla Al-Taher [Arabie saoudite] ; Mohammed Al-Nazawi [Arabie saoudite] ; Abdullah I. Al-Mubarak [Arabie saoudite] ; Mahmoud Kandeel [Arabie saoudite, Égypte] | Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design |
000356 (2019) |
Fahad Almutairi ; Mohammad Rehan Ajmal | Systematic Biophysical Insights into the Interaction of Anti MERS-CoV Drug Ribavirin with Major Transport Protein in Human Serum: In-Vitro Studies and Implications in Diabetes and Uremia |
000449 (2019) |
Abbas Al Mutair [Arabie saoudite, Australie] ; Zainab Ambani [Arabie saoudite] | Narrative review of Middle East respiratory syndrome coronavirus
(MERS-CoV) infection: updates and implications for practice |
000665 (2019) |
Bingpeng Yan ; Hin Chu ; Dong Yang ; Kong-Hung Sze ; Pok-Man Lai ; Shuofeng Yuan ; Huiping Shuai ; Yixin Wang ; Richard Yi-Tsun Kao ; Jasper Fuk-Woo Chan [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] | Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication |
000721 (2019) |
Amy Dighe [Royaume-Uni] ; Thibaut Jombart [Royaume-Uni] ; Maria D. Van Kerkhove [Suisse] ; Neil Ferguson [Royaume-Uni] | A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination |
000892 (2018) |
Sarah H. Alfaraj [Arabie saoudite, Canada] ; Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Ziad A. Memish [Arabie saoudite, États-Unis] | Middle East respiratory syndrome coronavirus intermittent positive cases: Implications for infection control |
000918 (2018) |
Awad Al-Omari [Arabie saoudite] ; Ali A. Rabaan [Arabie saoudite] ; Samer Salih [Arabie saoudite] ; Jaffar A. Al-Tawfiq [États-Unis] ; Ziad A. Memish [Arabie saoudite] | MERS coronavirus outbreak: Implications for emerging viral infections |
000A59 (2018) |
Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Philippe Gautret [France] | Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review |
000C67 (2017) |
Mukesh Mahajan ; Deepak Chatterjee ; Kannaian Bhuvaneswari ; Shubhadra Pillay ; Surajit Bhattacharjya | NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion |
000C92 (2017) |
Sarah H. Alfaraj ; Jaffar A. Al-Tawfiq ; Talal A. Altuwaijri ; Ziad A. Memish | Middle East Respiratory Syndrome Coronavirus and Pulmonary Tuberculosis Coinfection: Implications for Infection Control. |
001005 (2016) |
William J. Liu [République populaire de Chine] ; Min Zhao [République populaire de Chine] ; Kefang Liu [République populaire de Chine] ; Kun Xu [République populaire de Chine] ; Gary Wong [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; George F. Gao [République populaire de Chine] | T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV |
001127 (2016) |
K. H. Kim [Corée du Sud] ; T. E. Tandi [Corée du Sud, Cameroun] ; J. W. Choi [Corée du Sud] ; J. M. Moon [Corée du Sud] ; M. S. Kim [Corée du Sud] | Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications |
001165 (2016) |
Gytis Dudas [Royaume-Uni] ; Andrew Rambaut [Royaume-Uni, États-Unis] | MERS-CoV recombination: implications about the reservoir and potential for adaptation |
001345 (2016) |
Ji-Young Rhee ; Goohyeon Hong ; Kyoung Min Ryu | Clinical Implications of 5 Cases of Middle East Respiratory Syndrome Coronavirus Infection in a South Korean Outbreak. |
001668 (2015) |
Jie Zhou [République populaire de Chine] ; Hin Chu [République populaire de Chine] ; Jasper Fuk-Woo Chan [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] | Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis |
001675 (2015) |
Ziad A. Memish [Arabie saoudite] ; Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Rafat F. Alhakeem [Arabie saoudite] ; Abdullah Assiri [Arabie saoudite] ; Khalid D. Alharby [Arabie saoudite] ; Maher S. Almahallawi [Arabie saoudite] ; Mohammed Alkhallawi [Arabie saoudite] | Middle East respiratory syndrome coronavirus (MERS-CoV): A cluster analysis with implications for global management of suspected cases |
001768 (2015) |
Xian-Chun Tang [États-Unis] ; Wayne A. Marasco [États-Unis] | Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy. |
001863 (2015) |
Suzan D. Pas ; Marion Pg Koopmans ; Matthias Niedrig | Clinical implications of and lessons learnt from external assessment of Mers-CoV diagnostics |
001901 (2015) |
Burke A. Cunha [États-Unis] ; Marie Dumont [États-Unis] ; Eileen Abruzzo [États-Unis] | An adult returned traveler from Dubai hospitalized with an influenza-like illness (ILI): Middle East Respiratory Syndrome (MERS) or influenza? Infection control implications from a near MERS case. |
001911 (2015) |
Gary Crameri [Australie] ; Peter A. Durr [Australie] ; Jennifer Barr [Australie] ; Meng Yu [Australie] ; Kerryne Graham [Australie] ; Owen J. Williams [Australie] ; Ghazi Kayali [Égypte] ; David Smith [Australie] ; Malik Peiris [République populaire de Chine] ; John S. Mackenzie [Australie] ; Lin-Fa Wang [Australie, Singapour] | Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spread |